Results 281 to 290 of about 23,559,862 (313)
Some of the next articles are maybe not open access.

Racial and Socioeconomic Disparities in Lung Cancer Screening in the United States: A Systematic Review

Ca-A Cancer Journal for Clinicians, 2021
Dan J Raz   +2 more
exaly  

[Diagnostics of non-small cell lung carcinoma].

Duodecim; laaketieteellinen aikakauskirja, 2014
ALK inhibitor therapy is individual cancer treatment, in which the targeted drug therapy is directed to a patient group that is likely to benefit from the therapy. The detection in the tumor of ALK gene (anaplastic lymphoma kinase) rearrangement is a prerequisite for the ALK inhibitor therapy for non-small cell lung carcinoma.
Kaisa, Salmenkivi, Aija, Knuuttila
openaire   +1 more source

Unresectable non-small cell lung carcinoma

Revisiones en Cáncer, 2023
Ivana Sullivan   +2 more
openaire   +1 more source

Non-small Cell Lung Carcinoma

2008
Rodney J. Hicks, Robert E. Ware
openaire   +1 more source

[Chemoprevention in non-small cell lung carcinoma].

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.], 2004
ADAMO, Vincenzo   +3 more
openaire   +2 more sources

[Non-small-cell lung carcinoma].

Praxis, 2005
S, Pabst   +3 more
openaire   +1 more source

[Treatment of non-small cell lung carcinoma].

La Revue du praticien, 2003
Non small cell lung cancer is the most common histologic type (80 to 85%) with an incidence of 20 to 25,000 cases by year in France. Almost fifty per cent of cases are stage IV disease, at diagnosis and the treatment is palliative by chemotherapy. Locally advanced disease is treated by an association of chemo and radiotherapy.
openaire   +1 more source

An Update on the Immune Landscape in Lung and Head and Neck Cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle   +2 more
exaly  

Home - About - Disclaimer - Privacy